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Introduction
Falls and movement disorders are both common and disabling
in people living with idiopathic Parkinson’s disease.1,2[80_TD$DIFF] Over 60% of
people with Parkinson’s disease are predicted to fall at least once
annually, and 50% are expected to have recurrent falls.3,4 Falls lead
to a loss of independence, reduced quality of life, and increases in
morbidity, mortality, need for supported care, and care-giver
burden.1,5,6 The financial costs of falls are also substantial.7 The
annual direct costs of medical care for people with Parkinson’s
disease in the USA was USD12 164 higher than matched controls,8[82_TD$DIFF]
with falls being identified as a substantial contributor to increased
costs.
Physiotherapy for people with Parkinson’s disease aims to keep
them moving, prevent falls, and enable them to remain living at
home safely for as long as possible.9–12 Pharmacological manage-
ment of symptoms coupled with movement rehabilitation have
shown promise for reducing falls and improving mobility.9–17
Hospital and outpatient trials have reported positive effects for
movement rehabilitation strategies such as cueing,18 cognitive
strategies that focus attention and avoid dual task interference19
and progressive resistance strength training.20 Despite this,
exercises and movement rehabilitation therapy have received
limited attention in the published literature.4,11 This randomised,
controlled trial aimed to compare the efficacy of an integrated
physiotherapy exercise and rehabilitation programdelivered in the
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homewith a placebo control group that received a non-specific life
skills home-based program. The exercise program consisted of
movement strategy training based on studies by Morris and
Iansek,18,21 progressive resistance strength training, and education
on falls prevention and mobility. An integrated fall prevention
program combining strengthening, cueing and education was
provided, given the accumulating evidence for these interventions
for Parkinson’s disease.11,18,19 The programwas home based, so that
participants would not have to travel and would presumably feel
comfortable in their own premises.
Therefore, the research questions for this randomised, con-
trolled trial were:
1. For people with idiopathic Parkinson’s disease, does a 6-week,
comprehensive, home exercise program reduce falls and
disability and improve health-related quality of life?
2. Is the program cost-effective?
Method
Design
A randomised, controlled trial with concealed allocation,
assessor blinding and intention-to-treat analysis was conducted
in the Melbourne metropolitan region, Australia. A study protocol
with more detailed eligibility criteria and intervention descrip-
tions was previously published.22 Blinded assessors who were
registered physiotherapists performed all of the assessments.
Participants, therapists, centres
A total of 143 participants were assessed for eligibility and
133 were randomised into the study. Inclusion criteria were:
idiopathic Parkinson’s disease confirmed by a neurologist, modi-
fied Hoehn and Yahr (1967) stage  IV,23 Mini Mental State
Examination score  24,24 and community dwelling. Exclusion
criteria were: other health conditions that preclude safe partici-
pation in the exercise program, insufficient English to follow
instructions, and unwillingness to be assessed and treated at home.
Eligible participants were randomly allocated to either the
experimental group or the control group. Randomisation was
stratified according to referral source, and performed by an
independent entity using a computerised random number
generator.
Intervention
Experimental group
The 6-week program included a weekly 60-minute individual-
ised session delivered in the participant’s home, supervised by a
qualified and trained therapist who was guided by a physiothera-
pist. A physiotherapist also prescribed a weekly 60-minute
unsupervised session via pre-printed, individualised worksheets
that were explained to the participant by the treating therapist.
Thus, the total dosage of therapy each week was 120 minutes for
each of the 6 weeks.
People with Parkinson’s disease are often very de-conditioned.
Healthy adults typically receive up to 8 weeks of twice-weekly
training to obtain strength gains. At the time of the trial design,
6 weeks of twice-weekly therapy was argued to be adequate for
people with neurological impairments such as those with
Parkinson’s disease.25,26 A position statement by the American
Heart Association advised that 6-week interventions increased
strength and endurance in people with cardiovascular problems.27
The American College of Sports Medicine had similar advice with
regards to progressive models of resistance training for healthy
adults > 60 years of age.28 Moreover, a 6-week home programwas
thought to be feasible for people with Parkinson’s disease.
The experimental program comprised three individualised
components: progressive resistance strength training, movement
strategy training, and education about methods with which to
prevent falls. When the allocated 60-minute session was insuffi-
cient to complete all activities, the strength-training component
was prioritised. The unsupervised sessions repeated activities from
the therapist-guided sessions,withmodificationsmade for specific
individual needs or safety. To evaluate adherence and compliance
with the experimental intervention, each participant recorded the
activities that were performed, as well as perceived exertion for
each session (therapist-guided and unsupervised), on pre-printed
forms. Participants were monitored for adverse events during the
intervention and follow-up periods, and requested to report any
muscle soreness or joint stiffness from previous sessions. If this
occurred, theywere also asked to reportwhether they required any
health service due to the adverse event.
For the unsupervised sessions, participants received an
information pack containing a booklet with illustrations and
descriptions of exercises, and a Modified Rating of Perceived
Exertion scale.29 They also received an exercise log book, a
document with answers to frequently asked questions on strength
training, a booklet of falls prevention,30 and a standard help sheet
from Parkinson’s Victoria, listing support and resources.
Progressive resistance strength training
The strength-training component of the experimental inter-
vention focused on the major muscle groups that are essential for
functional gait and balance (quadriceps, glutei, hip abductors,
hamstrings, gastrocnemius, soleus and trunk muscles). Strength
training of these muscles was incorporated within step-ups, heel
raises, sit-to-stand movements, standing hip abduction exercises,
and trunk extension and rotation exercises. The American College
of Sports Medicine guidelines were used to develop the training
protocols, to ensure that the training stimulus and progression of
resistance were optimal.28,31,32[83_TD$DIFF] At each session, the participant
aimed to complete at least three different exercises, each
performed for two sets of [84_TD$DIFF]eight to 12 repetitions, with a 2-minute
rest between sets. Participants were able to progressively increase
resistance by using a weighted vest, a resistance band, weights, or
by altering their starting positions. The therapists trained the
participants to perform exercises safely and with correct form, and
assisted them in using the Modified Rating of Perceived Exertion
scale.29
Movement strategy training
The movement strategy training component of the experimen-
tal intervention was derived from previously established techni-
ques for people with Parkinson’s disease.21,32[85_TD$DIFF] These included the
use of visual, auditory, cognitive or proprioceptive cues and
attentional strategies to facilitate the ability of participants to
initiate and execute daily activities. Visual cues included the use of
white markers on the floor to step over, as well as written
instructions. Auditory cues included metronome cues and
rhythmical cues from music. The activities selected for movement
strategy training and their rate of progression were based on
individual abilities, needs, the home environment, and caregiver
support. The daily activities included: standing up and sitting
down;moving fromchair to chair; standing and reaching;walking;
walking whilst carrying objects; turning; and bed mobility.
Falls education
The falls education component of the experimental interven-
tion was based on a booklet published by the Commonwealth of
Australia entitled Don’t Fall for It! Falls Can Be Prevented.30 The
booklet is a guide for the prevention of falls in older people, and
contains information and advice on aspects of falls and safety.
Topics include: risk factors, keeping mobile, medication, vision,
safety in the home, and feet and footwear. Each session of the
experimental intervention reflected the booklet content, with
particular emphasis put on material relevant to the individual.
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Control group
The control group received a placebo intervention, which was a
life skills programof equal length to the experimental intervention,
and was delivered by trained allied health professionals, including
occupational therapists, physiotherapists and speech pathologists.
Weekly therapist contact times and self-directed homework
sessions were of comparable length to the experimental group
and consisted of guided education and discussion sessions on
topics of interest that were selected by participants from a pre-
defined syllabus. Available topics included relaxation, energy
conservation, fatigue management, voice, communication, swal-
lowing, diet, travel advice, and memory skills. None of the topics
contained content related to physical activity, exercise, walking, or
falls risk education. Participants in the control group were also
provided with the standard help sheet from Parkinson’s Victoria,
and for ethical considerations, a generic falls information sheet.
Outcome measures
Primary outcome
The primary outcome measure was falls, defined as an
unexpected event in which the participant comes to rest on the
ground, floor or lower level.33 All falls were monitored from the
initial pre-intervention assessment until the follow-up assessment
12 months after the intervention, via monthly falls calendars
returned via pre-paidmail. Each participant was required to record
any falls incidents by marking the date on the calendar and
indicating whether the fall was injurious (defined as any fall that
required medical attention or healthcare utilisation). Telephone
calls were made to remind participants to return their calendars
and to investigate any injurious falls. Each injurious fall was
followed up using a questionnaire to examine self-reported
healthcare utilisation and out-of-pocket expenses.
Secondary outcomes
The secondary outcome measures were changes in motor
disability and quality of life from the pre-intervention assessment
to the post-intervention and 12-month follow-up assessments.
Motor disability was scored using section III of the Movement
Disorder Society Unified Parkinson’s Disease Rating Scale (MDS-
UPDRS).34 The disease-specific Parkinson’s Disease Questionnaire
(PDQ-39)35 was used to score quality of life, and the generic
EuroQol-5D (EQ-5D-3L)36 allowed quality of life comparisons with
non-Parkinson’s disease populations.37 The EQ-5D-3L was con-
verted to a single utility index using the UK adult weights,38which
were based on the time trade-off method.
Economic evaluation
To determine the cost of the experimental intervention, the
direct cost of implementing the experimental program was
calculated, including the cost of travel, home visits, therapist
training and equipment. The economic analysis assumed that the
control group was a placebo intervention; therefore, no program
delivery costswere attributed to the control group. A health system
perspectivewas assumed, with the following outcomes of interest:
number of falls prevented, injurious falls, and health-related
quality of life.
Intention-to-treat analysis was undertaken. Costs were
reported as 2016 Australian dollars (AUD), and unit costs from
2012 were inflated using the Australian Bureau of Statistics health
inflation index. The questionnaire administered following an
injurious fall included detail about medical, medical ancillary,
diagnostic, and hospitalisation costs associated with falling events
during the 12-month follow-up period. It was assumed that each
person reporting an injurious fall would have a minimum of one
visit to a general practitioner. Hospital activity costs were obtained
from the National Hospital Cost Data Collection for 2012/2013.
These included admitted same-day (average cost of a same-day
admission), admitted overnight (average cost of an overnight
admission), non-admitted emergency department, and sub-acute
care. Unit costs for non-hospital services were based on the health
service costs for fractures reported by Watts et al in the recent
Osteoporosis Burden of Disease report.39[86_TD$DIFF]
Data analysis
The primary outcome was analysed in several ways: the
number of fallers during follow-up [87_TD$DIFF], the number of multiple fallers
during follow-up [88_TD$DIFF], falls rate during follow-up, and time to first fall.
A negative binomial regression model was used to compare the
number of falls and the falls rate per person per year in the two
groups, as this approach adjusts for varying durations of follow-up.
Injurious falls were analysed using the same methods. Secondary
outcome variables were compared between groups using analysis
of covariance, with baseline scores and intervention group entered
as independent variables.
Results
Flow of participants through the study
Of the 143 potential participants screened for eligibility,10were
excluded and 133 were randomised (Figure 1). One patient in the
experimental group and five in the control group did not receive
interventions. The numbers who attended the 12-month assess-
ment for testing of secondary outcomes were similar between
groups, with 55 in the experimental group and 53 in the control
group.
Baseline characteristics are reported in Table 1 and the groups
appear to be well matched. The mean age of the 80 men and
53 women was 70.6 years (range 46 to 86). The majority of
participants (66%) had mild Parkinson’s disease, with a modified
Hoehn and Yahr stage between I and II; 29% had moderate disease
severity (stage III) and 5.3% severe disability (stage IV). More than
half of the participants reported having had a fall in the previous
12months. Freezing of gait was self-reported by 35% of the sample
at baseline (taken from response to freezing of gait question of the
UPDRS part II). All participants in the control group and all except
three participants in the experimental group were taking
medications specific to Parkinson’s disease.
Falls during the 12-month follow-up
A total of 124 participants returned fall calendars after the
intervention period: 64 in the experimental group and 60 from the
control group. Table 2 summarises the data on fall rates. There
Table 1
Baseline characteristics of participants.
Characteristic All
(n =133)
Exp
(n=67)
Con
(n=66)
Age (yr), mean (SD) 71 (9) 71 (8) 71 (10)
Gender (M:F), n (%) 80:53 (60:40) 45:22 (67:33) 35:31 (53:47)
MMSE (0 to 30), mean (SD) 28.3 (1.6) 28.3 (1.5) 28.3 (1.8)
HY stage (1 to 4), median (IQR) 2 (2 to 3) 2 (2 to 3) 2 (2 to 3)
HY stage (1 to 4), n (%)
1 13 (10) 7 (10) 6 (9)
2 73 (55) 40 (60) 33 (50)
3 38 (29) 16 (24) 22 [63_TD$DIFF](33)
4 7 (5) 4 (6) 3 (5)
Freezing of gait (Y/N), n (%)a[62_TD$DIFF] 46 (35) 25 (37) 21 [64_TD$DIFF](32)
Fallen in last year, n (%) 73 [65_TD$DIFF](55) 38 (57) 35 (53)
No PD medication, n (%) 3 (2) 3 [66_TD$DIFF](4) 0 (0)
Levodopa only, n (%) 68 [67_TD$DIFF](51) 32 (48) 36 (55)
Combination therapy, n (%) 58 [68_TD$DIFF](44) 32 (48) 26 (39)
Non-levodopa, n (%) 1 (1) 0 (0) 1 (2)
 4 prescription medications, n (%) 80 [69_TD$DIFF](60) 40 (60) 40 (61)
Psychotropic medications, n (%) 59 [70_TD$DIFF](44) 28 (42) 31 (47)
Con= control group, Exp=experimental group, F= female, HY=Modified Hoehn &
Yahr scale, M=male, MMSE=Mini Mental State Exam, N=no, Y =yes, PD=Parkin-
son’s disease.
a Taken from question 2.13 of Movement Disorders Society Unified Parkinson’s
Disease Rating Scale.
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were 2255 falls reported over the 12-month follow-up period:
1401 in the experimental group and 854 in the control group. In the
experimental group, five participants reported > 100 falls over this
period (range 176 to 275), compared with one participant in the
control group, who reported 207 falls. There was no significant
between-group difference in the rate of falls (incidence rate ratio
[IRR] = 1.58, 95% CI 0.73 to 3.43). In the experimental group,
25 people did not fall and, in the control group, 17 did not fall.
There were 31 injurious falls. These were defined as a fall
resulting in attendance to a health service, and were reported by
24 participants. There were eight injurious falls in the control
group reported by eight participants and 23 injurious falls in the
experimental group experienced by 16 participants. One partici-
pant in the experimental group reported five separate injurious
falls. Detailed information was available from 22 participants for
27 of the injurious falls. Nine injurious falls resulted in a visit to a
hospital, of which six then required at least a one-night stay in
hospital. Seventeen participants consulted a general medical
practitioner on 21 occasions following a fall. Three participants
had a fracture due to a fall during the follow-upperiod: two fromthe
experimental group and one from the control group. The affected
sites includedvertebrae, hip and ankle. Themeanhealth service cost
of an injurious fall was AUD1995 (SD 4097) and the median cost
was AUD83. Amongst those who experienced an injurious fall, the
mean cost of the injurious fall was lower in the experimental
group compared with the control group; this difference was not
significantly different (MD AUD3055, 95% CI –244 to 6355).
A survival analysis of participant time to first fall did not show
any significant difference between the experimental and control
groups (log-rank test x2 = 0.79, p = 0.37) (Figure 2).
Changes in disability and health-related quality of life
Post-intervention measures of disability, as measured by the
MDS-UPDRS (part I, II and III), and health-related quality of life
(PDQ39, EuroQol VAS and EQ-5D-3L index score) are presented in
Table 3. There were no significant between-group differences for
the secondary outcome measures at the 12-month follow-up.
Economic analysis
The mean cost of delivering the intervention to participants in
the experimental group was AUD1596 per person. The intention-
to-treat analysis assumed that everyone completed the 6-week
[(Figure_1)TD$FIG]
Figure 1. Design and flow of participants through the trial.
aMotor disability was measured with the Movement Disorders Society Unified Parkinson’s Disease Rating Scale and quality of life was measured with the EuroQol-5D
questionnaire and the Parkinson’s Disease Questionnaire-39.
MMSE = Mini Mental State Examination, PD = Parkinson’s disease.
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program. The analysis included the costs of equipment, the
training physiotherapists, travel, and treatment time in the home
environment. The control group received placebo usual care;
therefore, no program delivery costs were attributed to the control
group. As there was no significant difference in outcomes between
the experimental and control groups, an incremental cost-
effectiveness ratio was not determined.
Compliance with the interventions
Regarding adherence, 66 participants in the experimental
group and 61 in the control group attended one or more sessions.
Adherence to the unsupervised sessions was high, with 62 of
experimental group and 51 of control group participants receiving
5 to 6 weeks of therapy. Four participants in the experimental
group and five in the control group attended three or fewer
sessions. No adverse events related to the intervention were
reported in the trial.
Discussion
This randomised trial found that 66% of peoplewith Parkinson’s
disease experienced one or more falls during the testing period.
There were no significant differences between groups in falls rates
during the 12-month follow-up period after therapy. Similarly,
therewas little difference between groups at the 12-month follow-
up for disability or health-related quality of life.
In relation to falls, the null findings of this placebo-controlled,
randomised trial agree with several recent large clinical trials of
movement rehabilitation, exercise therapy or physiotherapy for
people with mild to moderately severe Parkinson’s disease. For
example, an Australian trial with 231 participants by Canning et al
found that community-dwelling people with Parkinson’s disease
who received a 6-month home exercise program that included
progressive resistance strength training and falls education had
similar falls rates to those who received usual care.40[89_TD$DIFF] Therapeutic
exerciseswere performed for 40 to 60 minutes, [90_TD$DIFF]three times aweek,
for 6 months. Likewise, a large cluster-randomised trial in the
Netherlands with 699 participants reported similar falls rates and
health outcomes in people with Parkinson’s disease who received
intensive community-based therapeutic exercises for 16 weeks
compared to those who received standard care.15 Goodwin et al
conducted a pragmatic randomised trial in the UK, finding no
difference in falls between thosewho received 10weeks of therapy
compared to usual care.13[91_TD$DIFF] Likewise, the UK trial by Ashburn et al,
with 142 participants, did not show significant differences in falls
rates for thosewho received 6weeks of physiotherapy compared to
usual care.4A recent UK trial by Clarke et al reported that low-dose,
Table 2
Number of falls and fallers in each group, and ratio of falls risk (95% CI) between
groups.
Outcome measures Exp
(n=64)
Con
(n=60)
Ratio of falls risk
(95% CI)
All falls
number of falls 1.58 (0.73 to 3.43) a
total 1401 854
median (range) 1 (0 to 275) 1 (0 to 207)
fallers, n (%) 39 (60.9) 43 (71.7) 0.85 (0.66 to 1.09) b
multiple fallers, n (%) 30 (46.9) 28 (46.7) 1.00 (0.68 to 1.45) b
Injurious falls
number of falls 0.87 (0.24 to 3.10) a
total 23 8
median (range) 0 (0 to 5) 0 (0 to 1)
fallers, n (%) 16 (23.9) 8 (12.1) 1.97 (0.91 to 4.29) b
multiple fallers, n (%) 4 (6.0) 0 (0) 8.87 (0.49 to 161.52) b
a Incidence rate ratio.
b Relative risk.
[(Figure_2)TD$FIG]
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Figure 2. Kaplan-Meier survival curve showing time to first fall.
Table 3
Mean (SD) of groups and ANCOVA-adjusted mean difference (95% CI) between groups.
Outcome Groups ANCOVA-adjusted mean
between-group difference (95% CI)
Week 0 Week 6 Week 58
Exp Con Exp Con Exp Con Exp minus Con
(n=67) (n=66) (n=62) (n =58) (n =55) (n =53)
UPDRS Part I non-motor aspects of experiences of daily living
Questions 1.1 to 1.6 (0 to 16) 3.66 3.89 2.59 2.32 3.01 2.57 0.56
(3.27) (3.84) (2.45) (2.56) (2.59) (3.31) (–0.30 to 1.43)
Questions 1.7 to 1.13 (0 to 28) 8.04 7.57 6.91 7.07 7.65 7.32 0.45
(4.51) (4.58) (4.12) (3.48) (4.47) (3.11) (–0.82 to 1.72)
UPDRS Part II motor aspects of experiences of daily living (0 to 61) 15 16 13 15 14 16 1
(9) (8) (8) (7) (9) (8) (–1 to 3)
UPDRS Part III motor examination (0 to 77) 35 36 28 30 28 33 –2
(15) (15) (14) (13) (13) (15) (–7 to 2)
UPDRS Part IV motor complications (0 to 24) 4.00 3.37 3.81 3.85 3.70 3.52 –0.02
(4.23) (3.95) (4.51) (4.65) (4.33) (3.90) (–1.09 to 1.05)
PDQ-39 Summary Score Index (0 to 100) 23 24 21 20 22 22 1
(14) (15) (14) (14) (13) (14) (–2 to 5)
EQ-5D Visual Analogue Scale (0 to 100) 73 72 68 76 72 71 0
(15) (16) (15) (12) (17) (14) (–5 to 5)
EQ-5D Index Score (0 to 1) 0.67 0.63 0.66 0.65 0.67 0.64 0.01
(0.27) (0.28) (0.29) (0.27) (0.25) (0.30) (–0.08 to 0.11)
ANCOVA=analysis of covariance, Con=control group, EQ-5D=EuroQol 5D, Exp=experimental group, PDQ-39=Parkinson’s Disease Questionnaire, UPDRS=Unified
Parkinson’s Disease Rating Scale.
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patient-centred, goal-directed physiotherapy and occupational
therapywas not associatedwith significant gains; thiswas possibly
related to the modest dosage of therapy.41[92_TD$DIFF]
In contrast, a large US study of 200 participants by Li et al [93_TD$DIFF]
showed a significant reduction in falls for people who performed
intensive therapy twice weekly for 6 months.12 The intervention
group showed beneficial results from intense practice of physical
activities to improve balance, such as Tai Chi, highlighting the
importance of dosage in therapy outcomes. Likewise, the
randomised trial by Smania et al on 64 Italian participants found
beneficial effects on falls for an intensive program of balance
therapy delivered for 21 sessions of 50 minutes each.42[94_TD$DIFF] Gao and
colleagues explored the effects of regular Tai Chi on balance,
mobility and falls in 37 Chinese people with Parkinson’s disease
compared to a control group of 39 people who received no
intervention.43 By the 6-month follow-up, 22% of the group who
received 36 sessions of Tai Chi for 1 hour per session had
experienced a fall compared with 49% of control participants.
Along the same lines, in a study of 35 people with Parkinson’s
disease, Shen and Mak reported that 12 weeks of technology-
assisted balance and gait training five times per week reduced falls
to a greater extent than comparable dosages of strength training.44
Our own recent randomised trial of outpatient physiotherapy to
reduce falls in people with Parkinson’s disease17 showed a positive
effect on fall reduction. This used similar intervention, including
strength training, and movement strategies and fall education
twice weekly, but had an 8-week duration.
Other Parkinson’s disease physical rehabilitation trials of
comparatively high intensity and duration have shown positive
outcomes, highlighting the relevance of dosage to therapy
outcomes. For example, Monticone et al reported that people
with Parkinson’s disease who received intensive in-patient
rehabilitation within the context of a multi-disciplinary team
showed significantly better balance, mobility and quality of life
than people who received usual care of lower intensity.45[92_TD$DIFF] As
pointed out by Rochester and Espay,16 many exercise and
rehabilitation Parkinson’s disease trials appear to have delivered
relatively modest dosages of therapy. Some of these trials might
not have delivered sufficient intensity to afford the physiological
adaptations required to improve balance, mobility, strength and
falls in people living with Parkinson’s disease. The notable
feature of the trial of 70 people by Monticone et al was that
participants were admitted to hospital for a period of 8 weeks,
where they received high-dosage physiotherapy for 90 minutes
daily from expert clinicians.45[95_TD$DIFF] They also confined their sample to
people with comparatively mild Parkinson’s disease, who are
more likely to be responsive to physical therapy interventions.
However, it is unclear whether the improvements in balance
in the Monticone trial translated to reductions in falls. In sum,
the literature shows that both the content of therapy and the
dosage appear to be very important, as shown by the differential
results for therapies that targeted motor disabilities in many
investigations.4,12,46
As there was no between-group difference in the primary
outcome (falls rate) or secondary outcomes, the appropriate
economic method was a cost-minimisation analysis. The higher
resource costs for the experimental group suggest that interven-
tion should not be implemented in its current form. The resource
componentwas relatively intensive, as it relied onphysiotherapists
attending individuals in their home environment. The low capital
costs (weighted vests and steps were reusable across participants)
meant that there were few opportunities to improve efficiency, for
example if the scale (number of participants) was increased.
Increasing the intensity of the intervention would require a
significant improvement in the primary outcome in order for the
intervention to be considered cost-effective from a health system
perspective. In the current study, there were three fractures in
2255 falls, which is much less than previous hospital and out-
patient clinic trials in Parkinson’s disease.3,4 It could be speculated
that providing therapy in the familiar environment of the person’s
own home minimised the likelihood of injurious falls, although
this needs to be confirmed with further research.
Despite being one of the largest trials of movement rehabilita-
tion for falls in people with Parkinson’s disease, the present study
did have some limitations. The dosage of intervention was modest
and, in particular, the length of the program was 6 weeks, which
was comparatively short. This low dosage could have been a factor
that contributed to the failure to find a difference between groups
in people with mild to moderately severe Parkinson’s disease. The
combined therapy interventionwas associatedwith a reduced falls
rate for infrequent fallers, yet was not as effective for very high
frequency fallers who fell > 100 times in the follow-up period. This
result is consistent with Canning et al, who showed that exercise
therapy was associated with fewer falls in patients with mild
disease severity compared with those who were more severely
affected.40[96_TD$DIFF] It is possible that physiotherapy of much greater
intensity is required for peoplewith high levels of disability or very
high fall rates. Moreover, there may be a need for supervised,
centre-based programs for those with very severe disease
compared to home-based therapy with less supervision for those
with lower disease severity. This trial was entirely in people’s
homes. It cannot necessarily be generalised to interventions
delivered in hospital, clinic ormulti-disciplinary team settings. It is
also possible that therapy provided in the early stages of disease
progression is most helpful. Our experimental group did not
receive balance training, as there was no evidence at the time of
designing the trial that balance training reduced falls in
Parkinson’s disease. This too could be a topic of further research.
Another limitation of this trial was that participants were only
tested whilst ‘on’ their Parkinson’s disease medication, and the
relative contributions of movement rehabilitation and medication
to therapy outcomes could not be separated.
To conclude, fall rates were not substantially different in a
group that received 6 weeks of home physiotherapy compared to a
control group. The higher resource costs of the experimental group
intervention suggest that this particular program should not be
implemented in its current form. The dosage of therapy in the
experimental group might not have been high enough to enable
people to achieve long-term gains. Alternatively, the combination
of strength training, movement strategy training and falls
educationmight have been too complex to successfully implement
in a relatively short, home-based program. Future studies need to
more successfully optimise the content and dosage of therapy, as
well as tailoring treatment to individual needs.
What is already known on this topic: People with
Parkinson’s disease commonly fall, leading to injury, loss of
independence and reduced quality of life. Movement rehabili-
tation strategies delivered in hospital and outpatient settings
have benefits for people with Parkinson’s disease.
What this study adds: A home program of strength and
movement strategy training and falls education does not
prevent falls when applied at the dose used in this study
(6 weeks). The intervention did not significantly improve
disability and health-related quality of life.
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